MDR reg effective date extension planned by FDA; baseline reporting changes likely.
This article was originally published in The Gray Sheet
Executive Summary
MANUFACTURER MDR ANNUAL CERTIFICATION: EASING OF LANGUAGE is under consideration by FDA and likely will be included in the final version of the annual certification form for manufacturer medical device reporting. Speaking at a Feb. 7 session of a Regulatory Affairs Professionals Society meeting in Bethesda, Maryland, Chester Reynolds, associate director of the device center's Office of Surveillance and Biometrics, said that in response to industry concerns the agency is "discussing modifying the statement on the form" to make it less "absolute," and instead indicate all reportable events were submitted to the agency "to the best of [the manufacturer's] knowledge."
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.